Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Quantitative structure-activity relationship studies of threo-methylphenidate analogs.

Misra M, Shi Q, Ye X, Gruszecka-Kowalik E, Bu W, Liu Z, Schweri MM, Deutsch HM, Venanzi CA.

Bioorg Med Chem. 2010 Oct 15;18(20):7221-38. doi: 10.1016/j.bmc.2010.08.034. Epub 2010 Aug 19.

PMID:
20846865
2.

Synthesis and pharmacology of site-specific cocaine abuse treatment agents: restricted rotation analogues of methylphenidate.

Kim DI, Deutsch HM, Ye X, Schweri MM.

J Med Chem. 2007 May 31;50(11):2718-31. Epub 2007 May 10.

PMID:
17489581
4.

Biochemical and behavioral characterization of novel methylphenidate analogs.

Schweri MM, Deutsch HM, Massey AT, Holtzman SG.

J Pharmacol Exp Ther. 2002 May;301(2):527-35.

PMID:
11961053
5.

Synthesis and pharmacology of site specific cocaine abuse treatment agents: a new synthetic methodology for methylphenidate analogs based on the Blaise reaction.

Deutsch HM, Ye X, Shi Q, Liu Z, Schweri MM.

Eur J Med Chem. 2001 Apr;36(4):303-11. Erratum in: Eur J Med Chem 2001 Nov-Dec;36(11-12):961.

PMID:
11461755
6.

Synthesis and pharmacology of site-specific cocaine abuse treatment agents: 2-substituted-6-amino-5-phenylbicyclo[2.2.2]octanes.

Javanmard S, Deutsch HM, Collard DM, Kuhar MJ, Schweri MM.

J Med Chem. 1999 Nov 18;42(23):4836-43.

PMID:
10579846
7.

Synthesis and pharmacology of site-specific cocaine abuse treatment agents: 2-(aminomethyl)-3-phenylbicyclo[2.2.2]- and -[2.2.1]alkane dopamine uptake inhibitors.

Deutsch HM, Collard DM, Zhang L, Burnham KS, Deshpande AK, Holtzman SG, Schweri MM.

J Med Chem. 1999 Mar 11;42(5):882-95.

PMID:
10072685
8.
9.

Fourphit, an acylating phencyclidine derivative, attenuates cocaine-induced hyperactivity in rats.

Schweri MM, de Costa BR, Rice KC.

Pharmacol Biochem Behav. 1998 Jul;60(3):615-23.

PMID:
9678644
10.
12.
13.

Synthesis and pharmacology of irreversible affinity labels as potential cocaine antagonists: aryl 1,4-dialkylpiperazines related to GBR-12783.

Deutsch HM, Schweri MM, Culbertson CT, Zalkow LH.

Eur J Pharmacol. 1992 Sep 22;220(2-3):173-80.

PMID:
1425990
14.

Fourphit: a selective probe for the methylphenidate binding site on the dopamine transporter.

Schweri MM, Thurkauf A, Mattson MV, Rice KC.

J Pharmacol Exp Ther. 1992 Jun;261(3):936-42.

PMID:
1602399
15.
16.

The enantiomeric specificity of the antihypertensive activity of 1-(phenylthio)-2-aminopropane, a synthetic substrate analogue for dopamine beta-monooxygenase.

Herman HH, Husain PA, Colbert JE, Schweri MM, Pollock SH, Fowler LC, May SW.

J Med Chem. 1991 Mar;34(3):1082-5.

PMID:
2002450
18.
19.

Metaphit irreversibly inhibits [3H]threo-(+/-)-methylphenidate binding to rat striatal tissue.

Schweri MM, Jacobson AE, Lessor RA, Rice KC.

J Neurochem. 1987 Jan;48(1):102-5.

PMID:
3794693
20.
21.

The effects of surgical and chemical lesions on striatal [3H]threo-(+/-)-methylphenidate binding: correlation with [3H]dopamine uptake.

Janowsky A, Schweri MM, Berger P, Long R, Skolnick P, Paul SM.

Eur J Pharmacol. 1985 Jan 22;108(2):187-91.

PMID:
3920060
22.

[3H]GBR-12935: a specific high affinity ligand for labeling the dopamine transport complex.

Berger P, Janowsky A, Vocci F, Skolnick P, Schweri MM, Paul SM.

Eur J Pharmacol. 1985 Jan 2;107(2):289-90. No abstract available.

PMID:
3979428
23.

Strain differences in susceptibility to the convulsant actions of 3-carbomethoxy-beta-carboline.

Schweri MM, Paul SM, Skolnick P.

Pharmacol Biochem Behav. 1983 Dec;19(6):951-5.

PMID:
6657728
24.

Pharmacokinetic and pharmacodynamic factors contributing to the convulsant action of beta-carboline-3-carboxylic acid esters.

Schweri MM, Martin JV, Mendelson WB, Barrett JE, Paul SM, Skolnick P.

Life Sci. 1983 Oct 10;33(15):1505-10.

PMID:
6621253
25.

3-carboethoxy-beta-carboline (beta-CCE) elicits electroencephalographic seizures in rats: reversal by the benzodiazepine antagonist CGS 8216.

Skolnick P, Schweri MM, Paul SM, Martin JV, Wagner RL, Mendelson WB.

Life Sci. 1983 May 23;32(21):2439-45.

PMID:
6855447
26.
27.

An in vitro binding assay which differentiates benzodiazepine 'agonists' and 'antagonists'.

Skolnick P, Schweri MM, Williams EF, Moncada VY, Paul SM.

Eur J Pharmacol. 1982 Feb 19;78(1):133-6.

PMID:
6122583
28.
29.

Radial diffusion assay of tissue collagenase and its application in evaluation of collagenase inhibitors.

Yankeelov JA Jr, Wacker WB, Schweri MM.

Biochim Biophys Acta. 1977 May 12;482(1):159-72.

PMID:
193569

Supplemental Content

Loading ...
Support Center